Translational Control

p70 S6 Kinase Blocking Peptide

イイネ!(0) p70 S6 Kinase Blocking Peptide Data Sheet PDF
CSTコード 包装
希望納入価格 (円)
国内在庫 i
2012年2月9日11時30分 現在
ご登録代理店情報 i
カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更はこちら
#1205S100 μg16,000
ログインすると国内在庫状況がご確認いただけます。

p70 S6 Kinase抗体製品一覧

用途
免疫組織染色
貯法
-20℃
使用目的
p70 S6 Kinase (49D7) Rabbit mAb (#2708) の反応をブロックし、抗体の反応特異性を確認するために使用
社内データ

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using p70 S6 Kinase (49D7) Rabbit mAb #2708 in the presence of control peptide (left) or p70 S6 Kinase Blocking Peptide (right).

バックグラウンド

p70 S6 kinase is a mitogen activated Ser/Thr protein kinase that is required for cell growth and G1 cell cycle progression (1,2). p70 S6 kinase phosphorylates the S6 protein of the 40S ribosomal subunit and is involved in translational control of 5' oligopyrimidine tract mRNAs (1). A second isoform, p85 S6 kinase, is derived from the same gene and is identical to p70 S6 kinase except for 23 extra residues at the amino terminus, which encode a nuclear localizing signal (1). Both isoforms lie on a mitogen activated signaling pathway downstream of phosphoinositide-3 kinase (PI-3K) and the target of rapamycin, FRAP/mTOR, a pathway distinct from the Ras/MAP kinase cascade (1). The activity of p70 S6 kinase is controlled by multiple phosphorylation events located within the catalytic, linker and pseudosubstrate domains (1). Phosphorylation of Thr229 in the catalytic domain and Thr389 in the linker domain are most critical for kinase function (1). Phosphorylation of Thr389, however, most closely correlates with p70 kinase activity in vivo (3). Prior phosphorylation of Thr389 is required for the action of phosphoinositide 3-dependent protein kinase 1 (PDK1) on Thr229 (4,5). Phosphorylation of this site is stimulated by growth factors such as insulin, EGF and FGF, as well as by serum and some G-protein-coupled receptor ligands, and is blocked by wortmannin, LY294002 (PI-3K inhibitor) and rapamycin (FRAP/mTOR inhibitor) (1,6,7). Ser411, Thr421 and Ser424 lie within a Ser-Pro-rich region located in the pseudosubstrate region (1). Phosphorylation at these sites is thought to activate p70 S6 kinase via relief of pseudosubstrate suppression (1,2). Another LY294002 and rapamycin sensitive phosphorylation site, Ser371, is an in vitro substrate for mTOR and correlates well with the activity of a partially rapamycin resistant mutant p70 S6 kinase (8).

No product specific background information is currently available for this product.

  1. Pullen, N. and Thomas, G. (1997) FEBS Lett. 410, 78-82.
  2. Dufner, A. and Thomas, G. (1999) Exp. Cell Res. 253, 100-109.
  3. Weng, Q.P. et al. (1998) J. Biol. Chem. 273, 16621-16629.
  4. Pullen, N. et al. (1998) Science 279, 707-710.
  5. Alessi, D.R. et al. (1998) Curr. Biol. 8, 69-81.
  6. Polakiewicz, R.D. et al. (1998) J. Biol. Chem. 273, 23534-23541.
  7. Fingar, D.C. et al. (2002) Genes Dev. 16, 1472-1487.
  8. Saitoh, M. et al. (2002) J. Biol. Chem. 277, 20104-20112.
使用例
製品をご使用いただいて研究を発表されましたら、ぜひお知らせください
 
関連製品
2708   p70 S6 Kinase (49D7) Rabbit mAb

本製品は試験研究用です。

p70 S6 Kinase Blocking Peptide

Product Pathways

Tools

Applications